Genetic Analysis of Pediatric Primary Adrenal Insufficiency of Unknown Etiology: 25 Years’ Experience in the UK
Authors:
- Federica BuonocoreFBFederica Buonocore
- Avinaash MaharajAMAvinaash Maharaj
- Younus QamarYQYounus Qamar
- Katrin KoehlerKKKatrin Koehler
- Jenifer P SuntharalinghamJSJenifer P Suntharalingham
- Li F ChanLCLi F Chan
- Bruno Ferraz-De-SouzaBFBruno Ferraz-De-Souza
- Claire R HughesCHClaire R Hughes
- Rathi PrasadRPRathi Prasad
- Jeremy AllgroveJAJeremy Allgrove
- Edward T AndrewsEAEdward T Andrews
Open Access
- 11 May 2021
- journal article
- research article
- Published by The Endocrine Society in Journal of the Endocrine Society
- Vol. 5 (8) , bvab086
Abstract
Context Although primary adrenal insufficiency (PAI) in children and young people is often due to congenital adrenal hyperplasia (CAH) or autoimmunity, other genetic causes occur. The relative prevalence of these conditions is poorly understood. Objective We investigated genetic causes of PAI in children and young people over a 25 year period. Design, Setting and Participants Unpublished and published data were reviewed for 155 young people in the United Kingdom who underwent genetic analysis for PAI of unknown etiology in three major research centers between 1993 and 2018. We pre-excluded those with CAH, autoimmune, or metabolic causes. We obtained additional data from NR0B1 (DAX-1) clinical testing centers. Intervention and Outcome Measurements Genetic analysis involved a candidate gene approach (1993 onward) or next generation sequencing (NGS; targeted panels, exomes) (2013-2018). Results A genetic diagnosis was reached in 103/155 (66.5%) individuals. In 5 children the adrenal insufficiency resolved and no genetic cause was found. Pathogenic variants occurred in 11 genes: MC2R (adrenocorticotropin receptor; 30/155, 19.4%), NR0B1 (DAX-1; 7.7%), CYP11A1 (7.7%), AAAS (7.1%), NNT (6.5%), MRAP (4.5%), TXNRD2 (4.5%), STAR (3.9%), SAMD9 (3.2%), CDKN1C (1.3%), and NR5A1/steroidogenic factor-1 (SF-1; 0.6%). Additionally, 51 boys had NR0B1 variants identified through clinical testing. Although age at presentation, treatment, ancestral background, and birthweight can provide diagnostic clues, genetic testing was often needed to define the cause. Conclusions PAI in children and young people often has a genetic basis. Establishing the specific etiology can influence management of this lifelong condition. NGS approaches improve the diagnostic yield when many potential candidate genes are involved.Keywords
Funding Information
- Wellcome Trust (098513/Z/12/Z, 209328/Z/17/Z)
- National Institute for Health Research
- NIHR Great Ormond Street Hospital Biomedical Research Centre (IS-BRC-1215–20012)
- Barts Charity (MGU0438, MGU0458)
- Medical Research Council (MR/K020455/1, G0802796, MR/T02402X/1)
- German Research Foundation (KO 3588/2-1, HU 895/3-3, 3–4, 3–5, 4-1, 5-1, 5-2, 314061271, CRC-TRR205)
This publication has 58 references indexed in Scilit:
- Mutations in NNT encoding nicotinamide nucleotide transhydrogenase cause familial glucocorticoid deficiencyNature Genetics, 2012
- Mutations in the PCNA-binding domain of CDKN1C cause IMAGe syndromeNature Genetics, 2012
- MCM4 mutation causes adrenal failure, short stature, and natural killer cell deficiency in humansJournal of Clinical Investigation, 2012
- Clinical, Genetic, and Functional Characterization of Four Patients Carrying Partial Loss-of-Function Mutations in the Steroidogenic Acute Regulatory Protein (StAR)The Journal of Clinical Endocrinology & Metabolism, 2010
- Phenotypic characteristics of familial glucocorticoid deficiency (FGD) type 1 and 2Clinical Endocrinology, 2010
- Nonclassic Lipoid Congenital Adrenal Hyperplasia Masquerading as Familial Glucocorticoid DeficiencyThe Journal of Clinical Endocrinology & Metabolism, 2009
- Homozygous nonsense and frameshift mutations of the ACTH receptor in children with familial glucocorticoid deficiency (FGD) are not associated with long‐term mineralocorticoid deficiencyClinical Endocrinology, 2009
- Skewed X inactivation is associated with phenotype in a female with adrenal hypoplasia congenitaJournal of Medical Genetics, 2008
- A Novel Missense Mutation in Dax-1 with an Unusual Presentation of X-Linked Adrenal Hypoplasia CongenitaHormone Research in Paediatrics, 2007
- Severe loss‐of‐function mutations in the adrenocorticotropin receptor (ACTHR, MC2R) can be found in patients diagnosed with salt‐losing adrenal hypoplasiaClinical Endocrinology, 2006